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INTRODUCTION
Human metapneumovirus (hMPV), which was identified
recently in the Netherlands in respiratory samples from chil-
dren with acute respiratory symptoms, is enveloped non-seg-
mented RNA virus belonging to genus Metapneumovirus,
family Paramyxoviridae (1, 2). hMPV has been emerged as
an important etiologic agent of upper and lower respiratory
tract infections in individuals of all age, especially in young
children (3-8). The clinical manifestations associated with
hMPV ranges from upper respiratory tract infection includ-
ing cough, rhinorrhea, to lower respiratory tract diseases such
as severe bronchiolitis and pneumonia, similar to those of
human respiratory syncytial virus (RSV) (1, 9). Although the
prevalence of hMPV infection by using reverse transcriptase
PCR (RT-PCR) has been reported in several countries includ-
ing U.S.A., Canada, Australia, England, Japan, and Hong
Kong (3, 4, 8, 10-12), it is still unclear in Korean children.
The purpose of our study was to determine the frequency of
hMPV in hospitalized children with acute respiratory tract
disease in Korea.
MATERIALS AND METHODS
Respiratory samples and study subjects 
Between December 2003 and February 2005, we collected
nasal aspirates from 381 children under 15 yr (median age=19
months; range 0-144 months) who was hospitalized with res-
piratory infections in the Department of Pediatrics, Sanggye-
Paik Hospital, Inje University, Seoul, Korea. The specimens
were immediately transferred to the laboratory and each sam-
ple analyzed for RSV, adenovirus, influenza virus A and B, and
parainfluenza virus by immunofluorescent assay using fluo-
rescein-labelled monoclonal antibodies specific for each virus
(IMAGEN; Dako Diagnostics Ltd., Cambridgeshire, U.K.).
The specimens were stored at -70℃until further testing. An
informed consent was obtained at admission from patient’s
parents. The Ethics Committee of Inje University College of
Medicine, approved the study. 
RT-PCR 
RNA was extracted using the QIAmp Viral RNA Mini Kit
(Qiagen GmbH, Hilden, Germany). To synthesize cDNA,
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Human Metapneumovirus Infection in Hospitalized Children with Acute
Respiratory Disease in Korea 
Human metapneumovirus (hMPV) is a recently isolated virus, mostly associated with
acute lower respiratory infection in children, of which symptoms are similar to those
of respiratory syncytial virus (RSV) infection. The aim of our study was to determine
the frequency of hMPV in hospitalized children with acute respiratory tract disease
in Korea. Nasal aspirates from hospitalized children with respiratory infections under
15 yr old between December 2003 and February 2005 were included in the study.
Each sample was analyzed for RSV, adenovirus, influenza virus A and B, and para-
influenza virus by indirect fluorescent assay (IFA). F-gene sequences were used
for PCR for the detection and sequencing of hMPV. In total 381 samples, negative
samples in which any viral pathogen could not be identified by IFA were 231 cases.
hMPV was detected using reverse transcriptase-PCR (RT-PCR) in 28 of 231 (12.1%)
children who were not infected with another respiratory viruses. The hMPV-infect-
ed children were diagnosed as having pneumonia, bronchiolitis, bronchial asthma
exacerbation, croup, and upper respiratory tract infection. Most of the RT-PCR posi-
tive samples for hMPV were collected in winter season. These results suggest that
hMPV may be a responsible pathogen causing acute respiratory tract infection in
Korean children.
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0.2  g of of RNA was incubated in a solution containing 5
M random hexamer (Bioneer, Daejeon, Korea), 1 mM of
each dNTP, 2 units of RNase inhibitor, and 10 units of reverse
transcriptase (Bioneer, Daejeon, Korea) in a final volume of
20  L at 42℃ for 60 min. The cDNA (1  L) was subjected
to PCR analysis to detect the hMPV F-gene. Published F-gene
sequences of hMPV were used for PCR for the detection and
sequencing of hMPV (13). The forward primer sequence was
5′ -GCAACAATTGAA CTGATCTTCAGGAAAC-3′(AY-
304360-2; nucleotides 627 to 749) and the reverse primer
sequence was 5′ -GCAACATTGAACTGATCTTCAGGA-
AAC -3′(AY304360-2; nucleotides 1350 to 1376). When
the first PCR was negative, a nested PCR was performed
using forward primer [5′ -ACATGCCAACATCTGCAG-
GA CAAATAAAAC-3′(AY304360-2; nucleotides 698 to
727)] and the reverse primer [5′ -ACAT GCTGTTCACC-
TTCAACTTTGC-3′(AY304360-2; nucleotides 1285 to
1307)]. Amplification was performed in a 20  L reaction
mixture containing the following: 0.2  M of each primer;
200  M dATP, dCTP, dTTP, and dGTP; 10 mM Tris-HCl
(pH 9.0), 1.5 mM MgCl2, 40 mM KCl; 1 unit of Taq poly-
merase (Bioneer, Daejeon, Korea); and 1  L of cDNA sam-
ple (or the first round PCR product). Amplification was pre-
formed in a DNA thermal cycler (iCycler Thermal Cycler,
Bio-Rad Laboratories, Hercules, CA, U.S.A.). The amplifi-
cation conditions were as follows: 95℃ for 15 min followed
by 35 cycles of amplification (95℃ for 1 min, 55℃ for 1
min, 72℃extension for 1 min) and a final extension at 72℃
for 3 min. The amplified DNA fragments were size-separat-
ed on a 2% agarose gel with ethidium bromide, and visual-
ized with UV light (Fig. 1). To examine the sensitivity and
specificity of RT-PCR, ten of hMPV-positive RNA samples
(0.1  g) and ten of RSV-positive samples were used. The
amplified products were detected to 10 pg of RNA and no
product was detected from RSV positive samples. cDNA
from a clinical specimen was used as the positive control.
Phylogenic tree analysis
The PCR products were purified using Accuprep PCR Pu-
rification kit (Bioneer, Daejeon, Korea) and subsequently se-
quenced directly on both strands using BigDye Terminator
v3.1 Cycle Sequencing kit (Applied Biosystems, Foster, CA,
U.S.A.) with ABI prism 377 analyzer (Applied Biosystems).
Phylogenic trees were constructed using MEGA version 3.0
(14). Sequences are available from GenBank under accession
No. DQ092710-DQ092737. 
RESULTS
Detection of hMPV by RT-PCR
In total 381 samples, negative samples in which any viral
pathogen could not be identified by IFA were 231 cases (60.6
%). Respiratory syncytial virus was detected in 129/381 chil-
dren (33.8%). In addition, parainfluenza virus (n=9), influen-
za A (n=9), influenza B (n=2), and adenovirus (n=1) were
identified (Fig. 1). 
hMPV was detected using RT-PCR in 28 of 381 children
(7.3%) and in 12.1% of children who were not infected with
other common respiratory viruses. Of the 28 RT-PCR positive
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Fig. 1. Human metapneumovirus F gene amplificaion using nested
polymerase chain reaction. Lane 9 shows a DNA ladder marker.
Lanes 1 and 10 contain positive control (750 bp for first round PCR,
610 bp for second round PCR) Lanes 2 and 11 contain negative
control. Lanes 3-8 and lanes 12-17 contain samples 1-6. Sample
(lane 4 and 8) and (lane 13 and 17) show positive reactions and the
other samples show negative reaction.
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Fig. 2. Phylogenetic analysis of the F genes of hMPV isolated in
Korean children, which was reconstructed using neighbour-join-
ing method. Bootstrap proportions (500 replicates) are plotted at
the branches of phylogram to show support values. GenBank
accession numbers are DQ092710 to DQ092737.840 J.Y. Chung, T.H. Han, B.E. Kim, et al.
samples for hMPV, 25 cases (89.2%) were collected between
November 2004 and February 2005 (Table 1).
Clinical findings of hMPV positive patients
Clinical manifestations of the 28 children with hMPV infec-
tion are presented in Table 2. The median age was 15 months
(range 7-86 months) in the 28 patients. Symptoms included
cough (92.8%), fever (60.2%), sputum (42.8%), rhinorrhea
(39.2%), dyspnea (17.8%), diarrhea (7.2%), and vomiting
(7.2%). Expiratory wheezing and crackles were observed in
21.4% and 25% of the patients, respectively. Abnormal infil-
trates of chest radiograph were noted in 10 (35.7%) of the
28 patients. The hMPV-infected children were diagnosed as
having pneumonia (35.7%), bronchiolitis (28.5%), bronchial
asthma exacerbation (14.3%), croup (10.7%), and upper res-
piratory tract infection (7.1%). Six of 28 patients had a his-
tory of reactive airway disease. A 27-month-old girl who was
admitted with respiratory distress expired of cardiorespiratory
failure 2 days after admission without known bacteremia. Only
one patient of the 28 patients had underlying medical prob-
lem, chronic lung disease of prematurity.
Phylogenetic analyses of hMPV strains
Amplified products corresponding to part of the hMPV F
gene (750 bp) were visualized on 1.5% gels. The PCR prod-
ucts from each positive specimen were sequenced and were *RSV, respiratory syncytial virus; hMPV, human metapneumovirus.
Dec 2003-
Feb 2004
Mar-
May 2004
Jun-
Aug 2004
Sep-
Nov 2004
Dec 2004-
Feb 2005
No. of tested samples (No. of positive)
Common respiratory viruses
RSV 27 (2) 20 (0) 48 (6) 191 (99) 95 (22)
Influenza A 27 (1) 20 (0) 48 (0) 191 (1) 95 (7)
Influenza B 27 (0) 20 (0) 48 (2) 191 (0) 95 (0)
Parainfluenza 27 (0) 20 (0) 48 (3) 191 (3) 95 (3)
Adenovirus 27 (1) 20 (0) 48 (0) 191 (0) 95 (0)
hMPV 5 (0) 18 (3) 33 (0) 120 (8) 54 (17)
Table 1. Virus detection in nasal swabs in hospitalized children
with acute respiratory disease 
Case
No.
Sex
Age
(months)
Symptoms Diagnosis
Duration of hospi-
talization (days)
Underlying 
condition
Chest radiography
findings
1 F 5 Cough, Rh, sputum Bronchiolitis 4 None Hyperaeration
2 F 26 Fever, cough, stridor Croup 4 None WNL
3 M 12 Fever, cough, sputum Pneumonia 5 None WNL
4 F 52 Cough, Rh, wheezing Pneumonia 7 RAD RLL
5 F 52 Cough, wheezing B.A. 3 RAD  WNL
6 F 10 Fever, cough, sputum Bronchiolitis 3 None WNL
7 M 11 Cough Bronchiolitis 10 None WNL
8 M 8 Fever, Rh, sore throat URI 5 None WNL
9 M 15 Fever, Rh, cough, sputum Bronchiolitis 7 None LLL
10 F 24 Fever, Rh, cough Bronchiolitis 6 None Hyperaeration
11 F 14 Cough, Rh, wheezing Pneumonia 10 None WNL
12 M 32 Fever, Rh, cough, sputum Bronchiolitis 6 None RML
13 F 3 Fever, cough B.A. 5 None WNL
14 M 8 Cough, Rh, stridor Croup 7 RAD  WNL
15 M 22 Fever, cough Pneumonia 8 None WNL
16 M 37 Fever, cough, sputum,   Croup 7 RAD  Interstitial
wheezing, stridor, Rh
17 M 22 Fever, cough Bronchiolitis 7 None WNL
18 M 4 Cough B.A. 18 RDS WNL
19 M 79 Cough, wheezing B.A. 4 RAD  WNL
20 M 6 Wheezing Pneumonia 15 RAD Interstitial
21 M 86 Fever, cough, sputum Pneumonia 5 None Interstital
22 F 27 Fever, cough, sputum ARDS, expired 2 None BUL,  BLL
23 F 22 Fever, cough URI 8 None WNL
24 M 26 Fever, cough, sputum Pneumonia 6 None Interstitial
25 F 9 Cough, diarrhea  Bronchiolitis 7 None Hyperaeration
26 F 16 Fever, cough, sputum, Rh Pneumonia 5 None Interstitial
27 M 70 Fever, cough, sputum, Rh Pneumonia 6 None BLL
28 M 6 Cough, sputum Bronchiolitis 5 None Hyperaeration
Table 2. Clinical manifestations of hMPV infection
URI, upper respiratory tract infection; B.A., bronchial asthma; RAD, reactive airway disease; ARDS, acute respiratory distress syndrome; RDS, respira-
tory distress syndrome; Rh, rhinorrhea; WNL, within normal limit; BUL, both upper lobe infiltration; BLL, both lowe lobe infiltration; RML, right middle lobe
infiltration, Interstitial, interstitial infiltration.Human Metapneumovirus Infection in Children 841
consistent with hMPV. The 28 hMPV strains detected in this
study were classified into two distinct F lineages, 26 strains
belonged to genogroup A (A2) and two strains to genogroup
B (Fig. 2). 
DISCUSSION 
This study shows that hMPV is an important etiologic
agents among Korean children hospitalized with acute res-
piratory tract infections. The prevalence of hMPV detected
in nasopharyngeal samples from children with respiratory
infections of unknown etiology has varied from 1.5% to 21%
(1, 11, 15-18), but it has been unclear in Korea due to lack
of published reports. The difference of prevalence in several
studies may be explained by yearly variation in incidence,
different group of patients and primers used in PCR assays
for hMPV (15-18). Because we studied hospitalized children
only, actual prevalence of hMPV infections may be higher.
Some researcher suggested that hMPV cause lower respira-
tory tract infection in healthy children at a relatively high
frequency (19). 
It seems that hMPV shows a seasonal variation, with spo-
radic epidemics. In a study, hMPV was the most common
virus isolates during the winter season 2002-2003 in children
hospitalized for acute respiratory tract infection, but no spe-
cimen was found positive for hMPV in the following season
(18). Maggi et al. (7) reported that the incidence of hMPV
infection in infants varied from season to season over 3 yr peri-
od. The peak time of hMPV transmission in the Netherlands
was in December, in Canada in April, and in Hong Kong in
spring and early summer (1, 4, 12). Some reported that sig-
nificant hMPV activity occurred in every month of the year
with the peak incidence in the winter and spring seasons (19,
20). In our study, we detected 25 hMPV positive samples
from November to February during the winter season of 2004-
2005, with a peak in November. In the spring season of 2004,
we also detected three hMPV positive samples. But, the exact
prevalence of hMPV during the winter season of the 2003-
2004 in this study is uncertain due to small number of avail-
able respiratory specimens.
The clinical features of children with hMPV positive sam-
ples observed in our study were similar to those of previous
reports (8, 20). Exacerbation of asthma was observed in 14%
(4/28) of hMPV only positive patients in this study. Like other
viruses, such as hRSV and rhinoviruses, which have been sug-
gested as important triggers of asthma exacerbation in chil-
dren, an association between hMPV and asthma exacerbation
has been implicated. In a Finnish study, the positive rate of
hMPV was 32% (10/31) in hospitalized children with acute
wheezing during the period of peak of hMPV infection (21).
Although it may be possible that asthmatic bronchitis is trig-
gered by hMPV, it is not certain to conclude definitely the
association between and bronchial asthma (22). hMPV has
been suggested as a common and frequent etiologic agent of
bronchiolitis in young children (8, 23, 24). Some reported
that co-infection with RSV and hMPV may be a possible
cause of increasing clinical severity in hospitalized children
(25, 26), but others reported different results (7). The limi-
tations of this study are relatively short study period, small
number of samples in the first half of the 2004, which is not
sufficient to know the exact epidemiologic characteristics. The
data of combined infections of hMPV with other common
respiratory viruses are also lacking.
RT-PCR is more useful method than cell culture, which
has characteristics of slow growth and mild cytopathic effect
of hMPV, and is now used commonly in epidemiologic stud-
ies in various populations (27, 28). The strains of hMPV can
be divided into two major genetic lineages (1, 3). Variabili-
ty of hMPV genes may affect the sensitivity of study due to
limited available sequence information. We have performed
the analysis of F-gene as van den Hoogen et al. described (13),
which is known to have highly conserved sequence and allow
the differentiation of all four sublineages in several studies
(5, 8, 9, 13). Phylogenetic analysis of F gene sequences of
our strains showed highly nucleotide identity with viruses
belonging to genogroup A during the winter season of 2004-
2005, all belonged to A2. Otherwise, three hMPV positive
samples detected in spring of 2004 belonged to genogroup
B2 in two, genogroup A1 in one. An Italian study reported
striking variation in the overall circulation rates and co-circu-
lation of multiple strains in the same area in different years
(18).
This study suggests that hMPV may be an important etio-
logic agent of respiratory tract infection requiring hospital-
ization in children and two distinct groups of hMPV are co-
circulating in Korea. 
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